SARS-CoV/SARS-CoV-2 Spike antibody
MBS4754235-01mL	MyBiosource	0.1mL	EUR 450

Human IgG antibody Laboratories manufactures the anti-sars-cov spike flow cytometry antibody reagents distributed by Genprice. The Anti-Sars-Cov Spike Flow Cytometry Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Anti-Sars-Cov products are available in stock. Specificity: Anti-Sars-Cov Category: Spike Group: Flow Cytometry

SARS-CoV Spike Antibody
ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
ProSci	0.02 mg	EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
ProSci	0.1 mg	EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
ProSci	0.02 mg	EUR 206.18
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
ProSci	0.1 mg	EUR 523.7
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS Antibody (CoV) (Spike)
GenWay Biotech	0.1 mg	Ask for price

Flow Cytometry information

Anti Rat CD8a Flow Cytometry Monoclonal Clone OX8 PE
IMSARTCD8AOX8CPE25UG	Innovative research	each	EUR 72
Description: Anti Rat CD8a Flow Cytometry Monoclonal Clone OX8 PE

Anti Mouse CD5 Flow Cytometry Monoclonal Clone 5373 PE
IRTAMSCD55373CPE100UG	Innovative research	each	EUR 140
Description: Anti Mouse CD5 Flow Cytometry Monoclonal Clone 5373 PE

Anti Mouse CD5 Flow Cytometry Monoclonal Clone 5373 PE
IRTAMSCD55373CPE25UG	Innovative research	each	EUR 44
Description: Anti Mouse CD5 Flow Cytometry Monoclonal Clone 5373 PE

Anti Mouse CD28 Flow Cytometry Monoclonal Clone 3751 PE
IHMSAMSCD283751CPE100UG	Innovative research	each	EUR 135
Description: Anti Mouse CD28 Flow Cytometry Monoclonal Clone 3751 PE

Anti Mouse CD28 Flow Cytometry Monoclonal Clone 3751 PE
IHMSAMSCD283751CPE25UG	Innovative research	each	EUR 55
Description: Anti Mouse CD28 Flow Cytometry Monoclonal Clone 3751 PE

Anti Mouse CD45.2 Flow Cytometry Monoclonal Clone 1042 PE
IMSAMSCD4521042CPE100UG	Innovative research	each	EUR 100
Description: Anti Mouse CD45.2 Flow Cytometry Monoclonal Clone 1042 PE

Anti Mouse CD45.2 Flow Cytometry Monoclonal Clone 1042 PE
IMSAMSCD4521042CPE25UG	Innovative research	each	EUR 33
Description: Anti Mouse CD45.2 Flow Cytometry Monoclonal Clone 1042 PE

Anti Rat CD3 Flow Cytometry Monoclonal Clone G418 APC
IMSARTCD3G418CAPC100UG	Innovative research	each	EUR 190
Description: Anti Rat CD3 Flow Cytometry Monoclonal Clone G418 APC

Anti Rat CD3 Flow Cytometry Monoclonal Clone G418 APC
IMSARTCD3G418CAPC25UG	Innovative research	each	EUR 66
Description: Anti Rat CD3 Flow Cytometry Monoclonal Clone G418 APC

Anti Rat CD45 Flow Cytometry Monoclonal Clone OX1 APC
IMSARTCD45OX1CAPC100UG	Innovative research	each	EUR 220
Description: Anti Rat CD45 Flow Cytometry Monoclonal Clone OX1 APC

Anti Rat CD45 Flow Cytometry Monoclonal Clone OX1 APC
IMSARTCD45OX1CAPC25UG	Innovative research	each	EUR 80
Description: Anti Rat CD45 Flow Cytometry Monoclonal Clone OX1 APC

Anti Rat CD8a Flow Cytometry Monoclonal Clone OX8 APC
IMSARTCD8AOX8CAPC100UG	Innovative research	each	EUR 228
Description: Anti Rat CD8a Flow Cytometry Monoclonal Clone OX8 APC

Anti Rat CD8a Flow Cytometry Monoclonal Clone OX8 APC
IMSARTCD8AOX8CAPC25UG	Innovative research	each	EUR 80
Description: Anti Rat CD8a Flow Cytometry Monoclonal Clone OX8 APC

Anti Mouse CD31 Flow Cytometry Monoclonal Clone 390 PE
IRTAMSCD31390CPE100UG	Innovative research	each	EUR 140
Description: Anti Mouse CD31 Flow Cytometry Monoclonal Clone 390 PE

Anti Mouse CD31 Flow Cytometry Monoclonal Clone 390 PE
IRTAMSCD31390CPE25UG	Innovative research	each	EUR 55
Description: Anti Mouse CD31 Flow Cytometry Monoclonal Clone 390 PE

Anti Mouse CD8a Flow Cytometry Monoclonal Clone 5367 PE
IRTAMSCD8A5367CPE100UG	Innovative research	each	EUR 60
Description: Anti Mouse CD8a Flow Cytometry Monoclonal Clone 5367 PE

Anti Mouse CD8a Flow Cytometry Monoclonal Clone 5367 PE
IRTAMSCD8A5367CPE25UG	Innovative research	each	EUR 20
Description: Anti Mouse CD8a Flow Cytometry Monoclonal Clone 5367 PE